Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis

By Yamada Ryo   Suzuki Akari   Yamamoto Kazuhiko  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 249-258

Future Medicine

Access to resources Recommend Favorite

Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis

By Abdel-Nasser A. M.   Mahmoud M. H.   El Mansoury T. M.   Osman A. M.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 5, 2008-01 ,pp. : 329-336

Informa Healthcare

Access to resources Recommend Favorite

Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis

By Inanc N.   Dalkılıc E.   Kamalı S.   Kasapoglu-Günal E.   Elbir Y.   Direskeneli H.   Inanc M.  

Clinical Rheumatology, Vol. 26, Iss. 1, 2007-01 ,pp. : 17-23

Springer Publishing Company

Access to resources Recommend Favorite

Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis

By Alexiou Ioannis   Germenis Anastasios   Koutroumpas Athanasios   Kontogianni Anastasia   Theodoridou Katerina   Sakkas Lazaros  

Clinical Rheumatology, Vol. 27, Iss. 4, 2008-04 ,pp. : 511-513

Springer Publishing Company

Access to resources Recommend Favorite

Association of Anti-cyclic Citrullinated Peptide Antibodies with Clinical and Radiological Disease Severity in Rheumatoid Arthritis

By  

Current Rheumatology Reviews, Vol. 10, Iss. 2, 2014-09 ,pp. : 136-143

Bentham Science Publishers

Access to resources Recommend Favorite